This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

Michelle Chen
CBO at Insilico Medicine
Speaker

Profile

Michelle Chen is the Chief Business Officer at Insilico Medicine, a leader in the AI-powered drug discovery and development field.

She is responsible for the company’s strategies, business and corporate development, and the US operations. As a biotech executive, Michelle brings in 20+ years of experience in biopharma and technology industries, having worked at multi-national companies such as Roche, Merck, BioMarin, Agilent, as well as small biotech companies. She has a strong track record of success in company building, BD&L, M&A, R&D, marketing, and product commercialization.

Michelle has a Ph.D. in Biochemistry from the University of Washington, did her postdoctoral work at UCSF, and received Bioinformatics training at Stanford.

Agenda Sessions

  • Pharma goes all in: the rise of artificial intelligence

    15:30